My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 741 / DOI: 10.3332/ecancer.2017.741

Policy

The impact of a coordinated joint multidisciplinary breast cancer clinic

Introduction: Timely access to cancer treatment is expected to improve patients’ satisfaction and treatment outcome. A joint multidisciplinary breast cancer clinic (JMDBCC) was developed in January 2011 which aimed to accelerate access to breast cancer care. Here, we assess the efficacy of this approach.

Methods: Metric data of access to care in 2010 represent the pre-JMDBCC era while those during the subsequent 5 years (2011–2015 inclusive) represent the post-JMDBCC era. The JMDBCC is comprised of three separate but closely adjacent subclinics conducted at the same time representing the three main relevant clinic-based disciplines supported by a breast cancer coordinator. The primary aim of the clinic is to provide service to new patients within 7 days at each of the following stages: acceptance to first clinic visit (S1), first clinic visit to completion of appropriate investigations (S2), and completion of investigations to start of active treatment (S3). Thus, the total duration from acceptance to treatment (S1-3) is aimed to be within 21 days.

Results: Five hundred and fifty visits to the relevant clinics were recorded at the pre-JMDBCC era. Mean time metrics for new patients were as follows: 13, 18, 21, and 46 days for S1, S2, S3, and S1-3, respectively. The JMDBCC achieved reduction in all time metrics from the first year of implementation, reaching 3.6, 4.9, 7.3, and 15.9 days for S1, S2, S3, and S1-3, respectively, in year 2015. The number of new patients and total recorded clinic visits increased from 49/550, respectively, in the pre-JMDBCC era to 92/654, 183/1816, 158/2797, 174/4426, and 180/5883 in subsequent years.

Conclusions: A JMDBCC dramatically accelerates access to specialist multidisciplinary care. All institutions managing patients with breast cancer are encouraged to adopt such a coordinated service. The impact of an effective JMDBCC on disease-specific outcome should be addressed in future studies.

Keywords: multidisciplinary, breast cancer, clinic, coordinator

Categories:

Breast Care

Loading Article Metrics ... Please wait

Related articles

Research: Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy

Abstract | Full Article | PDF Published: 15 Aug 2017 / DOI: 10.3332/ecancer.2017.759

Review: Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy

Abstract | Full Article | PDF Published: 06 Jul 2017 / DOI: 10.3332/ecancer.2017.751

Special Issue: The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

Abstract | Full Article | PDF Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.746

Special Issue: Radioguided localisation of non-palpable lesions of the breast in Costa Rica: Review of results of our first 800 patients in private practice

Abstract | Full Article | PDF | Spanish Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.745

Special Issue: Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO)

Abstract | Full Article | PDF Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.744



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence